News

Congratulations to Dr. Florian Kuchenbauer (Kuchenbauer Lab), who has been awarded a 2020 Canada Innovation Fund (CFI)/BC Knowledge Development Fund (BCKDF) John R. Evans Leaders Fund (JELF) grant for his proposal “Exploring mitochondrial function as therapeutic target in acute myeloid leukemia and multiple myeloma".

Congratulations to Afsaneh Mojtabanezhad Shariatpanahi (Kuchenbauer Lab) who has been awarded an Echoridge Educational Foundation Scholarship in Continuing Education of Stem Cell Transplant Research & Development for her project entitled “Elucidating the molecular mechanism of high-risk multiple myeloma”.

Congratulations to Dr. Florian Kuchenbauer (Kuchenbauer Lab) who recently has been awarded a two-year Canadian Cancer Society Innovation Grant as part of a research team consisted of investigators from Simon Fraser University (Dr. Robert Britton, the Lead PI, and Drs. David Vocadlo and Matthew Nodwell) for their proposal entitled “Small molecule inhibitors of O-GlcNAc transferase: validation of a new anticancer target”.

Elizabeth Bulaeva (Eaves Lab) successfully defended her PhD thesis entitled “Analysis of a de novo c-MYC-induced model of human Acute Myeloid Leukemia”.

Building on a BC Cancer discovery from decades past, a new combination treatment has shown promise to overcome drug resistance and relapse in people with chronic myeloid leukemia. 

Building off the discovery of an enzyme called integrin-linked kinase (ILK) made by BC Cancer distinguished scientist Dr. Shoukat Dedhar 24 years ago, BC Cancer’s Drs. Xiaoyan Jiang and Shoukat Dedhar have made a significant advancement in understanding the role of this enzyme in blood cancers. 

Congratulations to Afsaneh who has been awarded a 4YF from the IOP program for her project entitled “Elucidating the molecular mechanism of high-risk multiple myeloma”.